List of works - Johnny Mahlangu

BAY 81-8973 demonstrated efficacy, safety and joint status improvement in patients with severe haemophilia A in the LEOPOLD I extension for ≤2 years

scientific article published on 29 February 2020

Bispecific Antibody Emicizumab for Haemophilia A: A Breakthrough for Patients with Inhibitors

scientific article published on 01 December 2018

Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non-interventional study in a real-world setting

scientific article published on 06 February 2019

Bleeding events and safety outcomes in persons with haemophilia A with inhibitors: A prospective, multi-centre, non-interventional study

scientific article published on 08 October 2018

Defining extended half-life rFVIII-A critical review of the evidence

scientific article published on 6 April 2018

Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South Africa

scientific article published on 18 February 2019

Guidelines for the management of hemophilia ⬇️

scientific article published on July 6, 2012

Haemophilia clinical care and research needs: Assessing priorities

scientific article published on 13 July 2018

Health-related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors-Results from the HAVEN 2 study

scientific article published on 21 October 2020

Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS)

scientific article published on 24 April 2019

Long-term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B-YOND extension study

scientific article published on 04 June 2020

Once-weekly prophylaxis with 40 IU/kg nonacog beta pegol (N9-GP) achieves trough levels of >15% in patients with haemophilia B: Pooled data from the paradigm™ trials

scientific article published on 24 September 2018

Palindromic-nucleotide substitutions (PNS) of hepatitis C virus genotypes 1 and 5a from South Africa ⬇️

scientific article published on May 10, 2011

Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII

scientific article published on 06 May 2018

Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study

scientific article published on 30 March 2020

Redefining prophylaxis in the modern era

scientific article published on 29 May 2020

Requirements to participate in haemophilia clinical trials

scientific article published on 01 April 2020

The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study

scientific article published on 14 November 2018

Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round Table

scientific article published on 23 March 2020

WFH Guidelines for the Management of Hemophilia, 3rd edition

scientific article published on 03 August 2020

List of works by Johnny Mahlangu